08/18/2025
1:50 PM | HCW Biologics (Filer)
| Form 8-K/A | |
08/18/2025
1:54 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2025
9:04 AM | HCW Biologics (Filer)
| Form NT 10-Q | |
08/14/2025
4:00 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2025
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
7:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
9:27 AM | HCW Biologics (Filer)
| Form 424B4 | |
Get the Latest News and Ratings for HCWB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
05/13/2025
3:18 PM | HCW Biologics (Filer)
| Form S-1/A | |
05/09/2025
4:28 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:29 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:30 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:31 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:33 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
12:55 PM | HCW Biologics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/28/2025
8:17 AM | HCW Biologics (Filer)
| Form DEF 14A | |
04/28/2025
7:45 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/28/2025
7:50 AM | HCW Biologics (Filer)
| Form ARS | |
04/22/2025
4:15 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
04/16/2025
3:26 PM | HCW Biologics (Filer)
| Form 424B3 | |
04/07/2025
5:06 AM | HCW Biologics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/01/2025
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
2:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
2:45 PM | HCW Biologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2025
4:00 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:29 PM | HCW Biologics (Filer)
| Form DEF 14A | |
02/11/2025
3:54 PM | HCW Biologics (Filer)
| Form PRE 14A | |
02/07/2025
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
6:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:37 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/22/2024
3:53 PM | HCW Biologics (Subject)
Wong Hing C (Filed by)
| Form SC 13D/A | |
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad) With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing.
Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis. Claim your free copy of “How to Survive the Next Financial Crisis” today |
11/22/2024
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
11:54 AM | HCW Biologics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
11/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K/A | |
MarketBeat All Access